Global Pathogen Analysis Service Ltd

Global Pathogen Analysis Service Ltd (GPAS Ltd) is a biotechnology startup based in the United Kingdom, with a mission to revolutionize the diagnosis and treatment of infectious diseases. The company is developing Whole Genome Sequencing-based metagenomic and individual pathogen clinical tools, aiming to create an 'always-on global pathogen metagenomics system' capable of identifying Pathogen X and providing early warnings of disease epidemics.

Founded in 2021, GPAS is backed by a world-leading pathogen genomics team from the University of Oxford, supported by the cloud computing scale and security of Oracle Inc, and generously funded by Larry Ellison. This collaboration positions GPAS as a global, turn-key solution that systematises the processing of data from genomic sequencing.

GPAS Ltd's partnership with the Ellison Institute of Technology, Oxford, as part of the Health and Medical Science Humane Endeavour, will further the development of pipelines for analyzing a broader range of pathogens and delivering solutions to laboratories, hospitals, and public health organizations globally.

With the potential to significantly impact the biotechnology and healthcare industries, GPAS Ltd's innovative approach and strategic alliances position it as a promising venture for venture capital investment.